Neurosoft Bioelectronics
Discover our deeptech vision with a medtech execution, advancing Brain-Computer Interfaces (BCI) through ultra-soft, minimally invasive technology. Learn how our innovative brain interfaces reduce risks like scar tissue and subdural hematomas, while our AI integration enhances data analysis and treatment outcomes for neurological disorders, unlocking new potential in neurotechnology.
Overview
Neurosoft Bioelectronics is a company in the neurotechnology sector based in Geneva. The company develops soft implantable electrodes designed to interface with the nervous system, aiming to improve care for patients with neurological disorders. Neurosoft Bioelectronics has created a technology that enables the manufacture of highly compliant neural interfaces, which can achieve long-term bio-integration in the body. These devices are intended to enhance therapeutic outcomes for patients and to enable new applications for neural interfaces that were previously unattainable.
Details
- Category
- Medical Equipment Manufacturing
- Headquarters
- Geneva
- Type
- Privately Held
- Founded
- 2020
- Locations
- Chemin des Mines 9 Geneva, CH
Funding
Total rounds: 8
Last round: Seed, Oct 6, 2024